drugset / Trial / NCT01867775

Mirtazapine for Sleep Disorders in Alzheimer's Disease

NCT01867775

Phase 3 Unknown 30 enrolled Brasilia University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether mirtazapine is effective in the treatment of sleep disorders in Alzheimers disease.

Timeline

Start
2012-05
Primary completion
2013-12
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 15 mg